LabConnect News

Connect to the Latest News From the World’s Leading Central Laboratory

Find out the latest news from LabConnect, the global central laboratory that connects you to confidence through premium services that simplify clinical research processes.

Cancer drug trials often at risk of bias, study finds

9/19/19

Randomized controlled studies are not all alike, as researchers determined about half of pivotal studies supporting recent cancer drug approvals in Europe had potential flaws.

Read More

GSK’s oral nicotine spray wins divided FDA panel’s backing despite abuse risks

9/19/19

With the federal spotlight on e-cigarette use, the FDA has grown increasingly wary of nicotine-based products with risks of abuse. That didn’t stop GlaxoSmithKline from winning a recommendation for its over-the-counter nicotine spray—but the backing didn’t come easy. An...

Read More